Anzeige
Mehr »
Login
Donnerstag, 13.05.2021 Börsentäglich über 12.000 News von 658 internationalen Medien
Sondermeldung zu Christi Himmelfahrt: Chance bei (Noch-) Geheimtipp besser jetzt ergreifen?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0BLFX ISIN: SE0001137985 Ticker-Symbol: BTPC 
Frankfurt
13.05.21
08:10 Uhr
0,124 Euro
+0,010
+8,36 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
ACTIVE BIOTECH AB Chart 1 Jahr
5-Tage-Chart
ACTIVE BIOTECH AB 5-Tage-Chart
RealtimeGeldBriefZeit
0,1250,16310:00

Aktuelle News zur ACTIVE BIOTECH Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
22.04.Annual Report 2020 Active Biotech AB (publ)167Active Biotech's Annual Report 2020 is now available for download at www.activebiotech.com. The Annual Report will only be digitally distributed. Download as PDF Lund, April 22, 2021...
► Artikel lesen
22.04.Annual Report 2020 Active Biotech AB (publ)-
ACTIVE BIOTECH Aktie jetzt für 0€ handeln
22.04.Active Biotech AB Interim report January - March 2021177Financing completed and good progress in the projects First quarter in brief Agreement signed for manufacturing of a topical ophthalmic formulation and capsules of laquinimod for use in clinical...
► Artikel lesen
20.04.Active Biotech: ACTIVE BIOTECH: NOTICE of ANNUAL GENERAL MEETING OF SHAREHOLDERS205The shareholders of Active Biotech AB (publ) are invited to the Annual General Meeting of shareholders to be held on Wednesday, May 19, 2021. Due to the situation resulting from the Corona virus, the...
► Artikel lesen
19.04.Active Biotech and NeoTX announce FDA Clearance of IND for Phase II Clinical Trial of Naptumomab234Phase IIa trial in non-small cell lung cancer expected to begin enrollment in the US in the second half of 2021 Lund Sweden, April 19, 2021 - Active Biotech AB (publ) (NASDAQ STOCKHOLM: ACTI) and...
► Artikel lesen
31.03.Number of shares and votes in Active Biotech194The number of shares and votes in Active Biotech has changed as a result of allotment of performance shares under the company's incentive program for the company's employees (Plan 2020/2024). Today...
► Artikel lesen
26.02.Number of shares and votes in Active Biotech229The number of shares and votes in Active Biotech has changed as a result of the recently completed rights issue. Today, the last trading day of the month, there are in total 217,854,720 shares and...
► Artikel lesen
11.02.Active Biotech AB reports Q4 results9
11.02.Active Biotech Year-end report January - December 2020361New strategic R&D plan implemented and financed Fourth quarter in briefTasquinimod The clinical study in multiple myeloma was presented at an oral poster session at the virtual American...
► Artikel lesen
04.02.CDMO Famar and Active Biotech Ink Clinical Manufacturing Deal8
04.02.Active Biotech: ACTIVE BIOTECH ENTERS INTO A MANUFACTURING AGREEMENT WITH FAMAR HEALTH CARE SERVICES FOR NEW FORMULATION OF LAQUINIMOD280Active Biotech AB (publ) (NASDAQ STOCKHOLM: ACTI) today announced it has reached a manufacturing agreement with Famar Health Care Services Madrid SAU ("Famar"), a European provider of pharmaceutical...
► Artikel lesen
04.02.Nasdaq Stockholm AB: Last day of trading in paid subscription rights (BTA) in Active Biotech AB (12/21)224Trading in Active Biotech AB paid subscription rights is to cease. The last trading day is February 8, 2021. Short name: ACTI BTA --------------------------- ISIN code: SE0015245592 --------------------------- Orderbook...
► Artikel lesen
26.01.Active Biotech's rights issue heavily oversubscribed1
07.01.Nasdaq Stockholm AB: Listing of subscription rights and paid subscription shares of Active Biotech AB (2/21)338With effect from 1/8/2021, the subscription rights in Active Biotech AB will be traded on the list for Equity rights. Trading will continue up until and including 1/19/2021. Instrument: Subscription...
► Artikel lesen
07.01.Adjustment of period for trading in subscription rights and interim shares in Active Biotech's rights issue3
29.12.20XFRA CAPITAL ADJUSTMENT INFORMATION - 29.12.2020342CAPITAL ADJUSTMENT INFORMATION - 29.12.2020:Das Instrument CA83364M5037 VIOR EXPL. MNS EQUITY wird ex Kapitalmassnahme gehandelt am 29.12.2020 The instrument CA83364M5037 VIOR EXPL. MNS EQUITY is traded...
► Artikel lesen
11.12.20Active Biotech Receive Milestone Payment From Neotx433PRESS RELEASE, Lund Sweden, December 11, 2020 - Active Biotech (NASDAQ STOCKHOLM: ACTI) Active Biotech AB (publ) today announce a milestone payment of USD 750 000 from the partner NeoTX Therapeutics...
► Artikel lesen
01.12.20Active Biotech's nomination committee appointed258PRESS RELEASE, Lund Sweden, December 1, 2020 - Active Biotech (NASDAQ STOCKHOLM: ACTI) In accordance with a decision made by the Annual General Meeting held on May 19, 2020, the Nomination Committee...
► Artikel lesen
30.11.20Report from extraordinary general meeting in Active Biotech and adjustment of previously communicated timetable for the rights issue247An extraordinary general meeting of Active Biotech was held on November 30, 2020. The meeting resolved, in accordance with the board's proposal, on a new share issue with pre-emptive rights for...
► Artikel lesen
25.11.20Active Biotech announces the final terms of the rights issue1
Seite:  Weiter >>
28 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1